{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2911, 
        2925
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3729, 
        3743
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4263, 
        4277
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4478, 
        4492
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4499, 
        4522
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2747, 
        2774
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        459, 
        488
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2254, 
        2289
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2820, 
        2826
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2892, 
        2900
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3079, 
        3085
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3150, 
        3156
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3223, 
        3229
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3710, 
        3718
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2827, 
        2843
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2901, 
        2910
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3086, 
        3102
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3157, 
        3173
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3230, 
        3246
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3719, 
        3728
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2796, 
        2806
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2869, 
        2879
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3056, 
        3065
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3128, 
        3137
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3199, 
        3209
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3272, 
        3282
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3371, 
        3380
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3470, 
        3479
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3579, 
        3587
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3689, 
        3697
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3878, 
        3887
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3989, 
        3998
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4089, 
        4098
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2776, 
        2777
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9311^MOH|PIMS|CCO|20160512121439|A85A9D8A1D8B480AFF287A54FEE0F15AC36DC6DE|ORU^R01|99999999999999999999|P|2.5|||||\nPID|1||^^^^MRN^HOSPITAL 11&9999&MOH~9999999999&CJ&ON^^^^JHN||XXXX^XXXXXX^||99999999|M|||99 XXXXXX XXXXX XXXXXX^^XXXXXXX^XX^X9X9X9^999|||||||||||||||||||N|\nOBR|1||BZ00604810|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160429|||69214^XXXXXXXXX^XXXX^XXXXX^^XX.||||||||||||20160512|||F||||||||\n\n\n\n\n\n\n\nPath report.gross description\n\n1.Specimen consists of 1 tan tissue corenE\\measuring 11 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\2.Specimen consists of 1 tan tissue corenE\\measuring 13 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\3.Specimen consists of 1 tan tissue corenE\\measuring 20 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\4.Specimen consists of 1 tan tissue corenE\\measuring 20 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\5.Specimen consists of 1 tan tissue corenE\\measuring 20 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\6.Specimen consists of 1 tan tissue corenE\\measuring 20 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\7.Specimen consists of 2 tan tissue coresnE\\measuring 5 and 16 mm in length by less than 1 mmnE\\in diameter and no fragments. Embedded in toto.nE\nE\\8.Specimen consists of 1 tan tissue corenE\\measuring 9 mm and 2 fragment measuring in totalnE\\4 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\9.Specimen consists of 2 tan tissue coresnE\\measuring 5 and 15 mm in length by less than 1 mmnE\\in diameter and no fragments. Embedded in toto.nE\nE\\10.Specimen consists of 1 tan tissue corenE\\measuring 14 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\11.Specimen consists of 1 tan tissue corenE\\measuring 17 mm and 1 fragment measuring in totalnE\\1 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\12.Specimen consists of 2 tan tissue coresnE\\measuring 5 and 21 mm in length by less than 1 mmnE\\in diameter and no fragments. Embedded in toto.nE\\\n\n\nPath report.microscopic observation\n\nTumour TypenE\\Adenocarcinoma, conventional typenE\nE\\ExtentnE\\# sites involved/total sites  2 / 12nE\\# cores involved/total cores  2 / 12nE\\Overall % tissue involved  1%nE\\% involvement in mostnE\\extensively involved core  10%nE\nE\\GleasonnE\\Overall Gleason Score (1?, worst)6 (3, 3)nE\\Highest Gleason Score (any site)6 (3, 3)nE\\% Gleason patterns 4, 5  0%nE\nE\\OthernE\\Perineural invasion     Not identifiednE\\Periprostatic fat invasion  Not identifiednE\\\n\n\nPath report.final diagnosis\n\n1.BIOPSY, PROSTATE (RIGHT BASE LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\2.BIOPSY, PROSTATE (RIGHT BASE MEDIAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 6/10 (PRIMARY 3, SECONDARY 3); 1/1 COREnE\\INVOLVED; 3% TISSUE INVOLVEMENT. ?see comment?nE\nE\\3.BIOPSY, PROSTATE (RIGHT MID LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\4.BIOPSY, PROSTATE (RIGHT MID MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\5.BIOPSY, PROSTATE (RIGHT APEX LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\6.BIOPSY, PROSTATE (RIGHT APEX MEDIAL)nE\\- FOCAL ATYPICAL SMALL ACINAR PROLIFERATIONnE\\(ASAP).nE\nE\\7.BIOPSY, PROSTATE (LEFT BASE LATERAL)nE\\- FOCAL ATYPICAL SMALL ACINAR PROLIFERATIONnE\\(ASAP).nE\nE\\8.BIOPSY, PROSTATE (LEFT BASE MEDIAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\9.BIOPSY, PROSTATE (LEFT MID LATERAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\10.BIOPSY, PROSTATE (LEFT MID MEDIAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 6/10 (PRIMARY 3, SECONDARY 3); 1/1 COREnE\\INVOLVED; 10% TISSUE INVOLVEMENT.nE\\?see comment?nE\nE\\11.BIOPSY, PROSTATE (LEFT APEX LATERAL)nE\\- FOCAL PROSTATIC INTRAEPITHELIAL NEOPLASIAnE\\(PIN), HIGH GRADE.nE\nE\\12.BIOPSY, PROSTATE (LEFT APEX MEDIAL)nE\\- FOCAL ATYPICAL SMALL ACINAR PROLIFERATIONnE\\(ASAP).nE\nE\\COMMENT #3nE\nE\\In the Right Mid Lateral biopsy, immunostains fornE\\P63 and HMWK are negative in the adenocarcinomanE\\and stain positively in the non-tumorous glandsnE\\and AMACR is positive in the adenocarcinoma.nE\nE\\COMMENT #10nE\nE\\In the Left Mid Medial biopsy, immunostains fornE\\P63 and HMWK are negative in the adenocarcinomanE\\and stain positively in the non-tumorous glandsnE\\and AMACR is positive in the adenocarcinoma.nE\\\n\n\nPath report.relevant Hx\n\nPSA Total: 6.4 ng/mLnE\nE\\Previous Surgery: T1c, Gleason 6nE\\Previous XRT: On Active Surveillance for restagenE\\biopsynE\\\n\n\n"
}